CLINICAL_TRIALS
withdrawal
· 2016-09-09
Clinical Trial Update: Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older [Phase 3]
Summary
A Phase 3 study evaluating MSRD-100 for atopic dermatitis was withdrawn, and the trial is no longer active.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merz North America, Inc. | Conditions: Atopic Dermatitis | Phase 3 | Status: WITHDRAWN